๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Radioimmunoguided surgery benefits for recurrent colorectal cancer

โœ Scribed by Schlomo Schneebaum; Joseph Papo; Moshe Graif; Mimi Baratz; Jack Baron; Yehuda Skornik


Publisher
Springer
Year
1997
Tongue
English
Weight
746 KB
Volume
4
Category
Article
ISSN
1068-9265

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Radioimmunoguided surgery with different
โœ Pierluigi Percivale; Sergio Bertoglio; Paolo Meszaros; Federico Schenone; Marco ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 33 KB

Sixty-four patients with recurrent or metastatic colorectal cancer underwent radioimmunoguided surgery (RIGS). Thirty patients (Group A) were preoperatively injected with radiolabeled monoclonal antibody (MAb) B72.3, a whole IgG1 that reacts with tumor-associated glycoprotein (TAG-72) antigen. Thirt

Radioimmunoguided surgery benefits in ca
โœ Sergio Bertoglio; Angelo Benevento; Pierluigi Percivale; Ferdinando Cafiero; Luc ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 34 KB ๐Ÿ‘ 2 views

Radioimmunoguided surgery (RIGS) with radiolabeled monoclonal antibodies (MoAbs) has been reported as useful in second-look colorectal cancer procedures to improve surgical decision-making by helping avoid needless extensive surgery and expanding curative resection to sites of recurrence that have b

Role of tumor-associated antigen express
โœ Sergio Bertoglio; Pierluigi Percivale; Federico Schenone; Alberto Peressini; Car ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 68 KB ๐Ÿ‘ 2 views

One hundred thirty-six patients with colorectal and breast cancer were enrolled in a retrospective study using radioimmunoguided surgery (RIGS) with Iodine-125 (I 125 ) radiolabeled B72.3 (Group A, 73 patients) and F023C5 (Group B, 63 patients) monoclonal antibodies (MAbs). The correlation between i